Cargando…

Nonalcoholic fatty liver disease represents a greater metabolic burden in patients with atherosclerosis: A cross-sectional study

How nonalcoholic fatty liver disease (NAFLD) is linked to atherosclerosis is still disputed. This study aimed to explore the association between NAFLD and atherosclerosis among adults in Shandong province, China. A total of 6849 individuals were enrolled in the final analyses for a community-based s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Jie, Wang, Yong, Yuan, Zhongshang, Liu, Lu, Zhao, Meng, Guan, Qingbo, Zhang, Haiqing, Li, Qiu, Xu, Jin, Gao, Ling, Zhao, Jiajun, Zhang, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426626/ https://www.ncbi.nlm.nih.gov/pubmed/30882706 http://dx.doi.org/10.1097/MD.0000000000014896

Ejemplares similares

Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients
por: Liu, Lu, et al.
Publicado: (2017)

Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease
por: Zhong, Fang, et al.
Publicado: (2021)

Thyroid function modifies the association between ratio of triglyceride to high-density lipoprotein cholesterol and renal function: a multicenter cross-sectional study
por: Yuan, Zhongshang, et al.
Publicado: (2015)

Different Contributions of Dyslipidemia and Obesity to the Natural History of Type 2 Diabetes: 3-Year Cohort Study in China
por: Liu, Lu, et al.
Publicado: (2019)

Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis
por: Xu, Xin, et al.
Publicado: (2015)

Non‐high‐density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance
por: Liu, Lu, et al.
Publicado: (2018)

Association of longitudinal changes in serum lipids with the natural history of subclinical hypothyroidism: A retrospective cohort study using data from the REACTION study
por: Zhong, Fang, et al.
Publicado: (2022)

Greater serum carotenoid levels associated with lower prevalence of nonalcoholic fatty liver disease in Chinese adults
por: Cao, Yi, et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
por: Sinn, Dong Hyun, et al.
Publicado: (2016)

Novel predictors of early atherosclerosis in nonalcoholic fatty liver disease
por: Abdulaziz, Badawy Abdulkhalik, et al.
Publicado: (2023)

Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
por: Miao, Lei, et al.
Publicado: (2022)

Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study
por: Liu, Jing, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease as an independent risk factor for carotid atherosclerosis
por: Rasool, Abid, et al.
Publicado: (2017)

Risk of premature coronary atherosclerosis in patients with nonalcoholic fatty liver disease
por: Taylan, Gökay, et al.
Publicado: (2022)

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
por: Perumpail, Brandon J, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease burden: Australia, 2019–2030
por: Adams, Leon A, et al.
Publicado: (2020)

Bidirectional temporal relationship between obesity and hyperinsulinemia: longitudinal observation from a Chinese cohort
por: Xu, Chao, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis
por: Kang, Min Kyoung, et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease in Hispanic Youth With Dysglycemia: Risk for Subclinical Atherosclerosis?
por: Bacha, Fida, et al.
Publicado: (2017)

Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients
por: Bae, Ye Seul, et al.
Publicado: (2020)

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease: Identifying the Disease Burden in Sri Lanka
por: Dassanayake, Anuradha S
Publicado: (2018)

Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children
por: Zhang, Jianwei, et al.
Publicado: (2023)

Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Yang, Meng, et al.
Publicado: (2021)

Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs
por: Yamada, Sohsuke, et al.
Publicado: (2017)

Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2019)

Novel metabolic phenotypes for extrahepatic complication of nonalcoholic fatty liver disease
por: Yi, Jiayi, et al.
Publicado: (2023)

SAT-109 tiRNA-5 Reflects the Severity of Mitochondrial Oxidative Stress in Nonalcoholic Fatty Liver Disease
por: Yang, Yashuang, et al.
Publicado: (2019)

Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis
por: Mo, Shuangyang, et al.
Publicado: (2023)

Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation
por: Wang, Jie, et al.
Publicado: (2015)

Effect of Nut Consumption on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Pan, Ling, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta‐analysis
por: Zhou, Yao‐Yao, et al.
Publicado: (2018)

The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE(−/−)FXR(−/−) Mice
por: Lee, Yenna, et al.
Publicado: (2021)

Explore the Mechanism of Astragalus mongholicus Bunge against Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Verification
por: Fu, Lili, et al.
Publicado: (2022)

Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease
por: Chen, Guanliang, et al.
Publicado: (2016)

Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
por: Nadinskaia, Maria, et al.
Publicado: (2021)

Clinical Features of Patients With COVID‐19 With Nonalcoholic Fatty Liver Disease
por: Huang, Rui, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old
por: Zheng, Jilin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ab0g1604u2dlc7r9te6jh29rhd